Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Joe Kiani Co-Founder Masimo Corp. The latest legal battle between Irvine-based medical device maker Masimo Corp. and Apple ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares closed ...

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Masimo (MASI – Research Report), with a price target of ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

The protracted legal wrangling between Apple and health wearable company Masimo has resulted ... to secure an injunction on the sale of Masimo's medical devices in the US. As it turned out ...

Masimo Corporation MASI delivered adjusted earnings per share (EPS) of 98 cents in the third quarter of 2024, up 30.7% year over year. The figure beat the Zacks Consensus Estimate by 16.7%. The ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 38%. Looking ahead, revenue ...

Masimo Corp (NASDAQ:MASI) reported healthcare revenues of $343 million for the third quarter, representing a 12% growth compared to the previous year. The company achieved a consolidated non-GAAP ...